Science & Enterprise subscription

Follow us on Twitter

  • Regulatory review of a drug to prevent allergic reactions to peanuts appears to be delayed by the shutdown of some… https://t.co/mSAKgI1Dry
    about 6 hours ago
  • New post on Science and Enterprise: Shutdown Delays FDA Peanut Allergy Drug Review https://t.co/vvspUdBnOM #Science #Business
    about 6 hours ago
  • Customized implants, produced on a 3-D printer and seeded with stem cells, are shown in tests with lab animals to… https://t.co/hc4xTlmSQq
    about 10 hours ago
  • New post on Science and Enterprise: 3-D Printed Implants Treat Spinal Cord Injury https://t.co/2ZiVpVvMIz #Science #Business
    about 10 hours ago
  • New contributed post on Science and Enterprise: https://t.co/z76z7xMWD3 Lighten The Load: Making Business Ownership Less Complex
    about 16 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

RNA Therapeutics Company Raises $30M in First Venture Round

Kevin Weeks

A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round

Modified Cancer Drug Hastens Bone Fracture Healing

Leg in cast

A current drug for leukemia, with a simple protein chemically added, is shown in tests with lab mice to accelerate the healing of broken bones. . . . → Read More: Modified Cancer Drug Hastens Bone Fracture Healing

New Processes Devised to Boost Antibiotics

MRSA bacteria

Researchers in chemistry at two institutions report new techniques that lab tests show modify current antibiotics to make them more effective against infections that resist today’s antibiotics. . . . → Read More: New Processes Devised to Boost Antibiotics

Bio-Friendly Film Material Devised from Silk, Carbon Nanotubes

Carbon nanotubes

Materials scientists and engineers developed a new material with the natural mechanical and degradable properties of silk, but configured as a film better suited for flexible biomedical devices. . . . → Read More: Bio-Friendly Film Material Devised from Silk, Carbon Nanotubes

BASF Licensing Precise Crispr Editing from Broad Institute

Crispr-Cas9 illustration

The global chemical company BASF is licensing a more precise form of genome editing from the Broad Institute, a genetics research center affiliated with Harvard University and MIT. . . . → Read More: BASF Licensing Precise Crispr Editing from Broad Institute

Genome Editing, Informatics Lead to New Antibiotic

Antibiotics from engineered bacteria

Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics. . . . → Read More: Genome Editing, Informatics Lead to New Antibiotic

Small Business Grant Aims to Cut Animals in Toxicity Testing

Lab mouse

A grant from National Institute of Health supports work by a start-up enterprise in Indiana to better estimate doses needed to test drugs for toxicity and reduce the number of animals needed for those tests. . . . → Read More: Small Business Grant Aims to Cut Animals in Toxicity Testing

Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

T-cells illustration

A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells. . . . → Read More: Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

Jet Fuel from Carbon Waste Powers Virgin Atlantic flight

Richard Branson at Gatwick

A Virgin Atlantic flight arriving earlier today from Orlando, Florida to London’s Gatwick airport is the first to use a biofuel made from fermented carbon-rich industrial waste gases. . . . → Read More: Jet Fuel from Carbon Waste Powers Virgin Atlantic flight

$29.5M Funding Raised for Sinus Drug Delivery Company

Sinus doctor

A company developing a drug delivery technology to treat chronic sinus conditions is raising $29.5 million in its second venture financing round. . . . → Read More: $29.5M Funding Raised for Sinus Drug Delivery Company